Connecticut Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Sell
4,166
-434
-9% -$208K 0.08% 102
2026
Q1
$2.26M Sell
4,600
-382
-8% -$207K 0.09% 93
2025
Q4
$2.89M Buy
4,982
+120
+2% +$67.9K 0.13% 78
2025
Q3
$2.36M Sell
4,862
-132
-3% -$61.4K 0.1% 89
2025
Q2
$2.02M Sell
4,994
-18
-0.4% -$7.53K 0.1% 95
2025
Q1
$2.49M Sell
5,012
-54
-1% -$29.2K 0.13% 78
2024
Q4
$2.64M Buy
5,066
+155
+3% +$85.2K 0.13% 64
2024
Q3
$3.04M Sell
4,911
-175
-3% -$104K 0.15% 76
2024
Q2
$2.81M Buy
5,086
+244
+5% +$140K 0.15% 80
2024
Q1
$2.81M Buy
4,842
+54
+1% +$30.3K 0.15% 76
2023
Q4
$2.54M Buy
4,788
+816
+21% +$395K 0.15% 82
2023
Q3
$2.01M Buy
3,972
+2,557
+181% +$1.36M 0.14% 79
2023
Q2
$738K Buy
1,415
+801
+130% +$432K 0.05% 118
2023
Q1
$354K Buy
614
+18
+3% +$10.1K 0.03% 173
2022
Q4
$328K Buy
+596
New +$316K 0.03% 150

Other funds holding TMO

Connecticut Wealth Management's TMO Position: Q2 2026 in Review

Connecticut Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 9.4% in Q2 2026, selling an estimated $208K and leaving 4,166 shares worth $2.09M. The position accounts for 0.08% of the portfolio, ranked #102.

Connecticut Wealth Management first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.04M in Q3 2024. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Connecticut Wealth Management held 4,166 shares of Thermo Fisher Scientific worth $2.09M as of Q2 2026.
  • Connecticut Wealth Management sold 434 Thermo Fisher Scientific shares in Q2 2026, an estimated $208K.
  • Thermo Fisher Scientific made up 0.08% of Connecticut Wealth Management's portfolio in Q2 2026, its #102 holding.
  • Connecticut Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Connecticut Wealth Management's Thermo Fisher Scientific position peaked at $3.04M in Q3 2024.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.